セッション

Frequent somatic alterations involving programmed death ligands in EBV-related lymphomas

[演者] Keisuke Kataoka (片岡 圭亮):1,2
[著者] Hiroaki Miyoshi (三好 寛明):3, Ayako Demachi-Okamura (岡村 文子):4, Seiji Sakata (坂田 征士):5, Lucile Couronne:6,7, Yasunori Kogure (木暮 泰寛):1, Akito Dobashi (土橋 映仁):5, Yasuharu Sato (佐藤 康晴):8, Kenji Nishida (西田 賢司):8, Yuichi Shiraishi (白石 友一):9, Hiroko Tanaka (田中 洋子):9, Kenichi Chiba (千葉 健一):9, Yosaku Watatani (綿谷 陽作):1, Yusuke Shiozawa (塩澤 裕介):1, Kenichi Yoshida (吉田 健一):1, Masashi Sanada (真田 昌):10, Motohiro Kato (加藤 元博):11, Kiyotaka Kuzushima (葛島 清隆):4, Satoru Miyano (宮野 悟):9, Yasunori Ota (大田 泰徳):12, Koji Izutsu (伊豆津 宏二):13, Tadashi Yoshino (吉野 正):8, Olivier Hermine:6,7, Kengo Takeuchi (竹内 賢吾):5, Yoshiki Akatsuka (赤塚 美樹):4,14, Koichi Ohshima (大島 孝一):3, Seishi Ogawa (小川 誠司):1
1:Dept. Pathol. Tum. Biol., Kyoto Univ., Kyoto, Japan, 2:Div. Mol. Oncol., Natl. Cancer Cent. Res. Inst., Tokyo, Japan, 3:Dept. Pathol., Kurume Univ. Sch. Med., Kurume, Japan, 4:Div. Immunol., Aichi Cancer Cent. Res. Inst., Nagoya, Japan, 5:Pathol. Proj. Mol. Target, Cancer Inst., Tokyo, Japan, 6:Dept. Clin. Hematol., Necker Hosp., AP-HP, Paris, France, 7:Imagine Inst., Paris, France, 8:Dept. Pathol., Okayama Univ., Okayama, Japan, 9:Human Genome Cent., Inst. Med. Sci., Univ. Tokyo, Tokyo, Japan, 10:Dept. Advanced Diag., Nagoya Med. Cent., Nagoya, Japan, 11:Children Cancer Cent., Natl. Cent. Child Health Develop, Tokyo, Japan, 12:Dept. Pathol., Toranomon Hosp., Tokyo, Japan, 13:Dept. Hematol., Natl. Cancer Cent. Hosp., Tokyo, Japan, 14:Dept. Hematol., Fujita Health Univ., Toyoake, Japan

Combination of Tet2 loss-of-function and RHOAG17V expression leads to T-cell lymphoma in mice

[演者] Tran B. Nguyen:1,2,3
[著者] Mamiko Sakata-Yanagimoto:4,5, Manabu Fujisawa:1, Shigeru Chiba:4,5
1:Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan, 2:Department of Hematology, Falcuty of Medicine, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam, 3:Stem Cell Transplantation Zone, Blood Transfusion Hematology Hospital, Ho Chi Minh City, Vietnam, 4:Department of Hematology, Falcuty of Medicine, University of Tsukuba, Ibaraki, Japan, 5:Department of Hematology, University of Tsukuba Hospital, Ibaraki, Japan

Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma

[演者] Manabu Fujisawa (藤澤 学):1
[著者] Mamiko Sakata-Yanagimoto (坂田-柳元 麻実子):1, Kota Fukumoto (福本 浩太):1, Daisuke Komori (小森 大輔):1, Shoko Nishizawa (西澤 翔子):1, Swarna Tanzima:1, Maiko Kiryu (桐生 真依子):1, Terukazu Enami (榎並 輝和):1, Masafumi Muratani (村谷 匡史):2, Kenichi Yoshida (吉田 健一):3, Seishi Ogawa (小川 誠司):3, Kosei Matsue (末永 孝生):4, Naoya Nakamura (中村 直哉):5, Kengo Takeuchi (竹内 賢吾):6, Koji Izutsu (伊豆津 宏二):7, Katsuya Fujimoto (藤本 勝也):8, Takanori Teshima (豊嶋 崇徳):8, Hiroaki Miyoshi (三好 寛明):9, Koichi Ohshima (大島 孝一):9, Shigeru Chiba (千葉 滋):1
1:Department of Hematology, University of Tsukuba, Ibaraki, Japan, 2:Department of Genome Biology, University of Tsukuba, Ibaraki, Japan, 3:Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 4:Hematology/Oncology Department, Kameda Medical Center, Chiba, Japan, 5:Department of Pathology, Tokai University School of Medicine, Isehara, Japan, 6:Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan, 7:Department of Hematology, Toranomon Hospital, Tokyo, Japan, 8:Department of Hematology, Hokkaido University, Sapporo, Japan, 9:Department of Pathology, Kurume University, Kurume, Japan

Integrated analysis of primary central nervous system lymphoma

[演者] Kenichi Yoshida (吉田 健一):1
[著者] Yotaro Ochi (越智 陽太郎):1, Yuichi Shiraishi (白石 友一):2, Yusuke Okuno (奥野 友介):3, Tomoya Isobe (磯部 知弥):4, Hiromichi Suzuki (鈴木 啓道):1, Azusa Hayano (早野 あずさ):5, Jumpei Homma (本間 順平):6, Hiroaki Hondoh (本道 洋昭):6, Junya Fukai (深井 順也):7, Koji Kajiwara (梶原 浩司):8, Makoto Ideguchi (出口 誠):8, Yoshihiro Komohara (菰原 義弘):9, Naoki Yajima (矢島 直樹):10, Naoto Tsuchiya (土屋 尚人):10, Masakazu Sano (佐野 正和):10, Yasuo Iwadate (岩立 康男):11, Kenichi Chiba (千葉 健一):2, Ai Okada (岡田 愛):2, Hiroko Tanaka (田中 洋子):2, Satoru Miyano (宮野 悟):2, Ryuya Yamanaka (山中 龍也):5, Seishi Ogawa (小川 誠司):1
1:Dept. of Pathology and Tumor Biology, Kyoto Univ., Kyoto, Japan, 2:Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 3:Dept. of Pediatrics, Nagoya University, Nagoya, Japan, 4:Dept. of Pediatrics, The University of Tokyo, Japan, 5:Kyoto Prefectural University of Medicine, Kyoto, Japan, 6:Department of Neurosurgery, Toyama Prefectural Central Hospital, Toyama, Japan, 7:Dept. of Neurological Surgery, Wakayama Medical University, Wakayama, Japan, 8:Dept. of Neurosurgery, Yamaguchi University, Yamaguchi, Japan, 9:Department of Cell Pathology, Kumamoto University, Kumamoto, Japan, 10:Department of Neurosurgery, Niigata University, Niigata, Japan, 11:Department of Neurosurgery, Chiba University, Chiba, Japan

Targeted sequencing of primary central nervous system lymphoma (PCNSL)

[演者] Keiichiro Hattori (服部 圭一朗):1
[著者] Mamiko Sakata-Yanagimoto (坂田-柳元 麻実子):1,2, Yasuhito Suehara (末原 泰人):1, Yasuhisa Yokoyama (横山 泰久):1, Takayasu Kato (加藤 貴康):1,2, Naoki Kurita (栗田 尚樹):2, Naoshi Obara (小原 直):1,2, Yuichi Hasegawa (長谷川 雄一):2, Shigeru Chiba (千葉 滋):1,2
1:Hematol., University of Tsukuba, Ibaraki, Japan, 2:Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

詳細検索